GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OptiBiotix Health PLC (FRA:OB3) » Definitions » Buyback Yield %

OptiBiotix Health (FRA:OB3) Buyback Yield % : -2.76 (As of Jun. 08, 2024)


View and export this data going back to 2018. Start your Free Trial

What is OptiBiotix Health Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

OptiBiotix Health's current buyback yield was -2.76%.


OptiBiotix Health Buyback Yield % Historical Data

The historical data trend for OptiBiotix Health's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OptiBiotix Health Buyback Yield % Chart

OptiBiotix Health Annual Data
Trend Jul10 Jul12 Nov14 Nov15 Nov16 Nov17 Nov18 Dec20 Dec21 Dec22
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -2.25 -2.09 - -4.16

OptiBiotix Health Semi-Annual Data
Jul12 Jan13 May14 Nov14 May15 Nov15 May16 Nov16 May17 Nov17 May18 Nov18 May19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -0.10 -8.16 -

Competitive Comparison of OptiBiotix Health's Buyback Yield %

For the Biotechnology subindustry, OptiBiotix Health's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OptiBiotix Health's Buyback Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OptiBiotix Health's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where OptiBiotix Health's Buyback Yield % falls into.



OptiBiotix Health Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

OptiBiotix Health's Buyback Yield for the fiscal year that ended in Dec. 2022 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0.558) / 13.4050329
=-4.16%

OptiBiotix Health's annualized Buyback Yield for the quarter that ended in Jun. 2023 is calculated as

Buyback Yield=Net Issuance of Stock(Annualized) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) * Annualized Factor / Market Cap
=- (0 + 0) * 2 / 8.34394905
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the annualized semi-annual data, the Repurchase of Stock and Issuance of Stock data used here is two times the semi-annual (Jun. 2023) data.


OptiBiotix Health Buyback Yield % Related Terms

Thank you for viewing the detailed overview of OptiBiotix Health's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


OptiBiotix Health (FRA:OB3) Business Description

Traded in Other Exchanges
Address
Innovation Centre, Innovation Way, Heslington, York, GBR, YO10 5DG
OptiBiotix Health PLC is engaged in the field of healthcare. As a life science company, its prime focus lies in researching the area of biotechnology. Its activities include the identification of microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology, deriving potential health benefits. The company derives majority of the revenue from the sale of Functional Fibres. The company markets its products in the United Kingdom under trademark names such as OptiBiotix, SweetBiotix, and SkinBioTherapeutics.

OptiBiotix Health (FRA:OB3) Headlines

No Headlines